C. S. Lima

Effects of a physiotherapeutic protocol in cardiorespiratory, muscle strength, aerobic capacity and quality of life after hematopoietic stem cell transplantation

C. D. de Souza, A. Vigorito, L. C. Palhares, 2021, Hematology, transfusion and cell therapy.

Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.

H. Avet-Loiseau, L. Coignet, S. Alkan, 2004, Blood.

Adjuvant therapy for locally advanced renal cell cancer: A systematic review with meta-analysis

A. Sasse, E. Sasse, J. Lima, 2011, BMC Cancer.

Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression‐free survival in multiple myeloma

E. Braggio, E. Rego, V. Hungria, 2012, American journal of hematology.

from Multiple Myeloma Patients and Cell Lines

H. Avet-Loiseau, L. Coignet, S. Alkan, 2016 .

Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer

P. Moriel, M. B. Visacri, E. C. Pincinato, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Polymorphisms of VEGF, GSTM1 and GSTT1 genes in multiple myeloma risk

M. Ortega, C. D. de Souza, G. Lourenço, 2012, Hematological oncology.